Does ILOPROST Cause Mobility decreased? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Mobility decreased have been filed in association with ILOPROST (AURLUMYN). This represents 0.2% of all adverse event reports for ILOPROST.
8
Reports of Mobility decreased with ILOPROST
0.2%
of all ILOPROST reports
1
Deaths
7
Hospitalizations
How Dangerous Is Mobility decreased From ILOPROST?
Of the 8 reports, 1 (12.5%) resulted in death, 7 (87.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ILOPROST Alternatives Have Lower Mobility decreased Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT